Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019

• Published in: Archives of public health = Archives belges de santé publique Vol. 81; no. 1; pp. 1 - 12
• Main Authors: Ameme, Donne Kofi, Yeboah, Yaw Ofori, Odoom, John Kofi, Djokoto, Senanu Kwesi, Akyereko, Ernest, Mamudu, Abdulaziz, Diwura, Mukaila, Opare, William, Avevor, Patrick, Diamenu, Stanley, Ohene, Sally-Ann, Kenu, Ernest, Asiedu-Bekoe, Franklin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04-01-2023; BioMed Central; BMC
• Subjects: Circulating; Outbreak; Paralysis; Pastoralist; Poliovirus; Risk factors; Vaccination; Vaccine-derived; Vaccines; Ghana; Circulating; Outbreak; Vaccine-derived; Poliovirus; Pastoralist; Vaccination
• DOI: 10.1186/s13690-022-01021-y
• EISSN: 2049-3258
• ISSN: 0778-7367; 2049-3258

The global switch from trivalent oral poliovirus vaccine (OPV) to bivalent OPV in April 2016 without corresponding co-administration of inactivated poliovirus vaccine (IPV) until June 2018, created a cohort of poliovirus type 2 naïve children with risk of developing vaccine-derived poliovirus type 2 (VDPV2). In November and December 2019, two cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were confirmed in quick succession through Acute Flaccid Paralysis (AFP) surveillance in two nomadic pastoralist settlements in Oti Region. We investigated to determine the outbreak extent, identify risk factors and implement control and preventive measures.
We interviewed case-patients' families, abstracted immunization records, assessed AFP surveillance and conducted rapid OPV and IPV vaccination coverage surveys. Using AFP case definition of any child less than 15 years in the community with sudden onset of paralysis from July to November 2019 (in case-patient 1's district) and August to December 2019 (in case-patient 2's district), we conducted active case search. Stool samples from apparently healthy children and close contacts of the case-patients were collected and tested for poliovirus. We conducted environmental assessment of the community to identify potential risk factors.
Case-patient 1 was an eight-year-old female who had taken two doses of OPV while case-patient 2 was an eight-month-old male who had taken three out of required four OPV doses in addition to IPV at seven months. Families of both case-patients had either travelled to or received visitors from areas with confirmed cVDPV2. Of all children surveyed, eight (29.6%) of 27 and three (18.8%) of 16 eligible children in communities of case-patient 1 and 2 respectively had received required four doses of OPV. No AFP case was found in both communities and surrounding settlements. Both communities had no source of potable water and toilet facilities. A stool sample from a contact of case-patient 1 tested positive for cVDPV2.
Outbreaks of cVDPV2 occurred in insanitary, under-vaccinated nomadic pastoralist settlements in Oti Region. Three rounds of monovalent OPV vaccination campaigns for children under 5 years of age in the districts and region as well as countrywide IPV vaccination campaign for poliovirus type 2 naïve cohort were conducted.